Vext Science, Inc. (VEXTF)
0.1942
0.00 (0.00%)
USD |
OTCM |
Jan 16, 16:00
Vext Science EPS Diluted (Quarterly): -0.0106 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Oncolytics Biotech, Inc. | -0.1032 |
| Aurinia Pharmaceuticals, Inc. | 0.232 |
| Edesa Biotech, Inc. | -0.3157 |
| Lexaria Bioscience Corp. | -0.0746 |
| Xenon Pharmaceuticals, Inc. | -1.147 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.628M |
| Revenue (Quarterly) | 12.67M |
| Total Expenses (Quarterly) | 15.30M |
| Enterprise Value | 79.35M |
| Gross Profit Margin (Quarterly) | -1.82% |
| Profit Margin (Quarterly) | -20.74% |
| Earnings Yield | -41.81% |
| Normalized Earnings Yield | -49.95 |